Zinc metalloproteinase ZmpC suppresses experimental pneumococcal meningitis by inhibiting bacterial invasion of central nervous systems
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zinc metalloproteinase ZmpC suppresses experimental pneumococcal meningitis by inhibiting bacterial invasion of central nervous systems
Authors
Keywords
-
Journal
Virulence
Volume 8, Issue 8, Pages 1516-1524
Publisher
Informa UK Limited
Online
2017-05-11
DOI
10.1080/21505594.2017.1328333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MMP-9 in translation: from molecule to brain physiology, pathology, and therapy
- (2016) Behnam Vafadari et al. JOURNAL OF NEUROCHEMISTRY
- Acute bacterial meningitis in adults
- (2016) Fiona McGill et al. LANCET
- Evolutionary inactivation of a sialidase in group B Streptococcus
- (2016) Masaya Yamaguchi et al. Scientific Reports
- The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis
- (2015) Fabian D Liechti et al. Journal of Neuroinflammation
- Horizontal gene transfer: building the web of life
- (2015) Shannon M. Soucy et al. NATURE REVIEWS GENETICS
- Matrix Metalloproteinase Inhibition Lowers Mortality and Brain Injury in Experimental Pneumococcal Meningitis
- (2014) Fabian D. Liechti et al. INFECTION AND IMMUNITY
- The role of ZmpC in the clinical manifestation of invasive pneumococcal disease
- (2014) Amelieke J.H. Cremers et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study
- (2014) Rodrigo Lopez Castelblanco et al. LANCET INFECTIOUS DISEASES
- Parallel Evolution of Streptococcus pneumoniae and Streptococcus mitis to Pathogenic and Mutualistic Lifestyles
- (2014) M. Kilian et al. mBio
- The Causative Pathogen Determines the Inflammatory Profile in Cerebrospinal Fluid and Outcome in Patients with Bacterial Meningitis
- (2013) Denis Grandgirard et al. MEDIATORS OF INFLAMMATION
- Effect of vaccines on bacterial meningitis worldwide
- (2012) Peter B McIntyre et al. LANCET
- Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event
- (2012) Tanya Golubchik et al. NATURE GENETICS
- Occurrence and Evolution of the Paralogous Zinc Metalloproteases IgA1 Protease, ZmpB, ZmpC, and ZmpD in Streptococcus pneumoniae and Related Commensal Species
- (2012) M. Bek-Thomsen et al. mBio
- Assembly Mechanism of FCT Region Type 1 Pili in Serotype M6Streptococcus pyogenes
- (2011) Masanobu Nakata et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dual Protective Mechanisms of Matrix Metalloproteinases 2 and 9 in Immune Defense against Streptococcus pneumoniae
- (2011) J.-S. Hong et al. JOURNAL OF IMMUNOLOGY
- Effect of Pneumococcal Conjugate Vaccination on Serotype-Specific Carriage and Invasive Disease in England: A Cross-Sectional Study
- (2011) Stefan Flasche et al. PLOS MEDICINE
- Glycosaminoglycan Binding Facilitates Entry of a Bacterial Pathogen into Central Nervous Systems
- (2011) Yung-Chi Chang et al. PLoS Pathogens
- Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization
- (2010) Anirban Banerjee et al. CELLULAR MICROBIOLOGY
- The evolution of gene duplications: classifying and distinguishing between models
- (2010) Hideki Innan et al. NATURE REVIEWS GENETICS
- The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion
- (2009) Satoshi Uchiyama et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PfbA, a Novel Plasmin- and Fibronectin-binding Protein ofStreptococcus pneumoniae, Contributes to Fibronectin-dependent Adhesion and Antiphagocytosis
- (2008) Masaya Yamaguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now